The impact of cellular senescence during ageing is well established, however senescence is now recognised to play a role in a variety of age related and metabolic diseases, such as cancer, autoimmune and cardiovascular diseases. It is therefore crucial to gain a better understanding of the mechanisms that control cellular senescence. In recent years our understanding of the intimate relationship between cell metabolism, cell signalling and cellular senescence has greatly improved. In this review we discuss the differing roles of glucose and protein metabolism in both senescent fibroblast and CD8 + T-cells, and explore the impact cellular metabolism has on the senescence-associated secretory phenotype (SASP) of these cell types.
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Introduction
Cellular senescence is a process in which cells enter a state of stable cell cycle arrest while maintaining metabolic activity. The term was first used to describe fibroblasts that have reached the end of their proliferative capacity in culture (replicative senescence) and in humans was found to be casually linked to telomere erosion (Hayflick and Moorhead, 1961; Bodnar et al., 1998) . Critically short telomeres trigger a DNA damage response, which can establish and maintain cell cycle arrest through the transcriptional regulator p53 and the cyclin dependent kinase inhibitor p21 (Harley et al., 1990) . Prolonged cellular stresses, such as non-telomeric DNA damage, hypoxia or increased reactive oxygen species (ROS) production can give rise to stress induced premature senescence (Chen et al., 1995) . Oncogenes are also prominent inducers of senescence (Serrano et al., 1997) . Consequently, senescence has historically been viewed as an irreversible mechanism that acts to prevent cancer, however, recent discoveries have implicated senescence in many physiological roles such as development (Storer et al., 2013) , tissue repair (Krizhanovsky et al., 2008) , wound healing (Jun and Lau, 2010; Demaria et al., 2014) , tumorigenesis (Munoz-Espin et al., 2013; Munoz-Espin and Serrano, 2014) and ageing (Baker et al., 2011 (Baker et al., , 2016 .
Senescence also occurs in the immune system with senescent immune cells being shown to have similar features to senescence fibroblasts; such as DNA damage, loss of proliferative capacity and high expression of p53 (Henson et al., 2014; Callender et al., 2018) . Although senescence can affect all aspects of our immune system, much of the deterioration in the protective immune response has been attributed to defective T-cell function as a result of T-cell senescence (Akbar et al., 2004; Nikolich-Žugich, 2005) . As a result, older individuals have an impaired response to vaccinations, greater susceptibility to infectious disease and the potential development of various age related diseases (McElhaney, 2005; Bruunsgaard, 2006; Franceschi and Campisi, 2014) .
Senescent T-cells can be identified through the expression of surface markers (CD27 + , CD28-, CCR7-, CD45RA + , KLRG1 + , CD57 + ) and although they can be found in young individuals, they increase substantially during ageing. Senescent CD8 + T-cells share many of the same characteristics as senescent fibroblasts such as, increased p53 and p38MAPK, and have been shown to have increased DNA damage and ROS production and a lack of proliferation (Henson et al., 2014) . Furthermore, in comparison to less differentiated T-cells, senescent T-cells secrete high levels of TNF-α and IFN-γ and maintain high levels of cytotoxic proteins perforin and granzyme B (Henson et al., 2014) . In addition to their role in aging, there is an ever growing appreciation that senescent T-cells also play a role in many chronic metabolic diseases such as cancer (Zelle-Rieser et al., 2016) , obesity (Shirakawa et al., 2016) and rheumatoid arthritis (Weyand et al., 2014) . In this article we will discuss the role of glucose and protein metabolism in cellular senescence in both fibroblasts and CD8 + T-cells with reference to how dysregulation of both impact the senescence associated secretory phenotype (SASP) of each cell type, ultimately highlighting key metabolic similarities and differences between senescent fibroblasts and T-cells.
